You are here

NAPROGENIX, INC.

Company Information
Address
UK-ASTECC 145 Graham Avenue
Lexington, KY 40506-0001
United States


http://www.naprogenix.com

Information

UEI: N1NBJ43SQGX7

# of Employees: 8


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $1,102,755.00

    DESCRIPTION provided by applicant This project aims to demonstrate that the evolution of plant biosynthetic pathways can be accelerated and driven to favor the synthesis of ligands which interact w ...

    SBIRPhase II2013Department of Health and Human Services National Institutes of Health
  2. NOVEL PHARMACOTHERAPIES FOR ALCOHOLISM, TOPIC #4409/24/2012- 03/23/2013

    Amount: $149,697.00

    Alcoholism is a complex condition in which there are many potential molecular and therapeutic targets for pharmacotherapy. This fast track SBIR contract aims to investigate compounds targeted on t ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  3. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $272,674.00

    DESCRIPTION (provided by applicant): The primary aim is to transfer a biotechnology platform for plant drug discovery from the academic laboratory to industry use (i.e. this application is directly re ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  4. Novel estrogen receptor ligands from plant genomics

    Amount: $699,216.00

    DESCRIPTION (provided by applicant): Human nuclear receptor (HNR) ligands have potential value as pharmacotherapies or chemopreventive agents for many hormone-responsive cancers. The primary aim of th ...

    STTRPhase II2010Department of Health and Human Services National Institutes of Health
  5. Potential anti-relapse drugs: a plant genomics approach

    Amount: $340,250.00

    DESCRIPTION (provided by applicant): Alcohol-induced neurodegeneration and the consequent dementia are important therapeutic targets in alcoholism. However, because alcohol-induced neurotoxicity has ...

    STTRPhase II2008Department of Health and Human Services National Institutes of Health
  6. Transgenic plant cells as a source of hepatoprotective drugs

    Amount: $249,230.00

    DESCRIPTION (provided by applicant): Alcoholic liver damage (ALD) is among the top ten causes of death in the USA, but existing therapeutic interventions are relatively ineffective. Hepatocytes are su ...

    STTRPhase II2007Department of Health and Human Services National Institutes of Health
  7. Hypericum extracts as potential anti-relapse medications in alcoholism

    Amount: $1,128,279.00

    DESCRIPTION (provided by applicant): Alcoholism is a complex disease and anti-relapse treatments should recognize this. For example, depression is a frequent precipitant of relapse (1) and is the most ...

    STTRPhase I2007Department of Health and Human Services National Institutes of Health
  8. Hypericum extracts as potential anti-relapse medications in alcoholism

    Amount: $183,669.00

    DESCRIPTION (provided by applicant): Alcoholism is a complex disease and anti-relapse treatments should recognize this. For example, depression is a frequent precipitant of relapse (1) and is the most ...

    STTRPhase II2007Department of Health and Human Services National Institutes of Health
  9. Novel estrogen receptor ligands from plant genomics

    Amount: $106,716.00

    DESCRIPTION (provided by applicant): Plants produce many types of molecules, such as chalcones flavones and flavonones, that interact with human estrogen receptors (ERs). Some of these may have therap ...

    STTRPhase I2006Department of Health and Human Services National Institutes of Health
  10. Novel estrogen receptor ligands from plant genomics

    Amount: $106,716.00

    DESCRIPTION (provided by applicant): Plants produce many types of molecules, such as chalcones flavones and flavonones, that interact with human estrogen receptors (ERs). Some of these may have therap ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government